Protecting Ovarian Function During Blood Cell Transplant
Treatments studied
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a hormone injection called goserelin can help preserve fertility and menstrual function in young women receiving a stem cell transplant for blood cancer. The transplant itself can damage ovaries, so researchers want to see if this medication protects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer or blood disorder requiring a stem cell transplant from a donor
- You are female, aged 14–50, with regular periods before treatment
- You have no severe heart, liver, or kidney problems
- You are not allergic to goserelin (the study medication)
- You have not gone through menopause
- You don't have other gynecological conditions like PCOS or endometriosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called goserelin can help preserve fertility and menstrual cycles in women undergoing stem cell transplantation for blood cancers. The goal is to see if this drug can prevent or reduce damage to the ovaries from the transplant procedure.
This study tests whether a medication called goserelin can help protect a woman's fertility and menstrual cycles during a stem cell transplant treatment for aplastic anemia (a blood disorder). The goal is to see if the medication prevents permanent damage to the ovaries from the transplant procedure.
This study transplants a healthy ovary from a sister to her sibling who has gone through early menopause. Researchers want to see if the transplanted ovary can help the recipient get pregnant naturally within four months.
This trial tests two hormone-blocking injections (leuprolide and goserelin) to suppress ovarian function in premenopausal women with breast cancer. It aims to see how well these drugs work when taken with standard hormone pills.
This trial is testing whether giving the drug goserelin in a different spot on the body works just as well for suppressing ovarian function in premenopausal women with hormone receptor positive breast cancer. You may be a fit if you've already been on goserelin shots in your abdomen for at least 6 months.
This study looks at transplanting ovarian tissue that was frozen before cancer treatment to help restore fertility and hormone function in people who survived sarcomas or blood cancers. It aims to see if this procedure is safe and effective.
Hear when a new Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.